Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders-Reference-Cited by-同舟云学术

Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

Published:2017-01-25 Issue:2 Volume:23 Page:198-206
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Walsh C. E.¹^ORCID,Workowski K.²,Terrault N. A.³,Sax P. E.⁴,Cohen A.⁵,Bowlus C. L.⁶,Kim A. Y.⁷,Hyland R. H.⁸,Han B.⁸,Wang J.⁸,Stamm L. M.⁸,Brainard D. M.⁸,McHutchison J. G.⁸,von Drygalski A.⁹,Rhame F.¹⁰,Fried M. W.¹¹,Kouides P.¹²,Balba G.¹³,Reddy K. R.¹⁴

Affiliation:

1. Icahn School of Medicine at Mount Sinai; Mount Sinai Hospital; New York NY USA

2. Emory University; Atlanta GA USA

3. University of California at San Francisco; San Francisco CA USA

4. Brigham and Women's Hospital and Harvard Medical School; Boston MA USA

5. Newark Beth Israel Medical Center; Barnabas Health; Newark NJ USA

6. University of California at Davis; Davis CA USA

7. Massachusetts General Hospital; Boston MA USA

8. Gilead Sciences Inc.; Foster City CA USA

9. University of California at San Diego; San Diego CA USA

10. Abbott Northwestern Hospital; Minneapolis MN USA

11. University of North Carolina at Chapel Hill; Chapel Hill NC USA

12. The Mary M. Gooley Hemophilia Center; Rochester NY USA

13. MedStar Georgetown University Hospital; Washington DC USA

14. University of Pennsylvania; Philadelphia PA USA

Funder

Gilead Sciences

AbbVie

Bristol-Myers Squibb

Eisai

Biotest

Merck

GlaxoSmithKline

Intercept Pharmaceuticals

NGM Biosciences

Takeda Pharmaceuticals U.S.A.

Jannsen

Galectin Therapeutics

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13178/fullpdf

Reference40 articles.

1. Past, present and future of hemophilia: a narrative review;Franchini;Orphanet J Rare Dis,2012

2. Hepatitis C viral infection in patients with hemophilia and hemolytic disorders;Orman;Clin Liver Dis,2012

3. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study;Eyster;J Acquir Immune Defic Syndr,1993

4. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study;Posthouwer;Blood,2007

5. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia;Zhang;Blood,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management;Journal of Multidisciplinary Healthcare;2022-10

2. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders;Turkish Journal of Gastroenterology;2022-05-26

3. The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia;Annals of Hepatology;2022-01

4. Clinical burden of hemophilia in older adults: Beyond bleeding risk;Blood Reviews;2021-12

5. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders;Virology Journal;2021-10-07